Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14542192 | 0.80 | GAA (0.48) | ALDH1A1LMNANPSR1KMT2AATM | |
| SCHEMBL14031813 | 0.74 | ESR1 (0.44) | ALDH1A1KMT2AATMSMN1; SMN2 | |
| SCHEMBL13879329 | 0.74 | DPP4 (0.40) | ALDH1A1KMT2AGAA | |
| SCHEMBL27559373 | 0.73 | KMT2A (0.38) | ALDH1A1KMT2AATMGAASMN1; SMN2 | |
| SCHEMBL13879233 | 0.73 | ALDH1A1 (0.37) | ALDH1A1KMT2AATMGAASMN1; SMN2 | |
| SCHEMBL27559390 | 0.73 | SLC7A5 (0.50) | ALDH1A1LMNAMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL14542190 | 0.72 | ALDH1A1 (0.44) | ALDH1A1LMNAKMT2AGAAKDM4E | |
| SCHEMBL3184772 | 0.72 | POLB (0.51) | ALDH1A1LMNAMAPTKMT2AATM | |
| SCHEMBL3936988 | 0.72 | LMNA (0.54) | ALDH1A1LMNAKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL30921159 | 0.70 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080241896-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE HYDROXYMETHYL-SUBSTITUTED PHENYLALANINE | AJINOMOTO CO., INC. (JP) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241896-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE HYDROXYMETHYL-SUBSTITUTED PHENYLALANINE | PAH, HPD, DAO | ALDH1A1 681/4885LMNA 3397/4885MAPT 4160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.